Frontiers in Medicine (Nov 2021)

High-Throughput Sequencing Profiles About lncRNAs and mRNAs of Ovarian Granulosa Cells in Polycystic Ovary Syndrome

  • Yanjun Zheng,
  • Yanjun Zheng,
  • Yanjun Zheng,
  • Yanjun Zheng,
  • Yanjun Zheng,
  • Yuehong Bian,
  • Yuehong Bian,
  • Yuehong Bian,
  • Yuehong Bian,
  • Yuehong Bian,
  • Richao Wu,
  • Richao Wu,
  • Richao Wu,
  • Richao Wu,
  • Richao Wu,
  • Wei Chen,
  • Wei Chen,
  • Wei Chen,
  • Wei Chen,
  • Wei Chen,
  • Linlin Fu,
  • Linlin Fu,
  • Linlin Fu,
  • Linlin Fu,
  • Linlin Fu,
  • Ping Li,
  • Ping Li,
  • Ping Li,
  • Ping Li,
  • Ping Li,
  • Ying Wang,
  • Ying Wang,
  • Ying Wang,
  • Ying Wang,
  • Ying Wang,
  • Xiao Yang,
  • Xiao Yang,
  • Xiao Yang,
  • Xiao Yang,
  • Xiao Yang,
  • Shigang Zhao,
  • Shigang Zhao,
  • Shigang Zhao,
  • Shigang Zhao,
  • Shigang Zhao,
  • Yuhua Shi,
  • Yuhua Shi,
  • Yuhua Shi,
  • Yuhua Shi,
  • Yuhua Shi

DOI
https://doi.org/10.3389/fmed.2021.741803
Journal volume & issue
Vol. 8

Abstract

Read online

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, which is characterized by ovulatory dysfunction, clinical and/or biochemical androgen excess, polycystic ovaries on ultrasound and genetic heterogeneity. It was well-accepted that many lncRNAs and mRNAs were associated with PCOS, however, remain unclear. Therefore, the purpose of our study was to examine different expression profiles of lncRNAs and mRNAs in ovarian granulosa cells (GCs) in PCOS and Controls, and identify the correlation between lncRNAs, mRNAs and clinical parameters. Sixty five PCOS patients and 65 Controls were enrolled in this study and adopted standard long agonist protocols or GnRH antagonist protocols. Then 6 GCs samples in each group were subjected to high-thoughput sequencing and the remaining samples were used for the further verification by quantitative real-time PCR (qRT-PCR). Gene Oncology (GO), Kyoto Encyclopedia Genes and Genomes (KEGG) enrichment analysis were performed. We predicted the relationship between lncRNAs and mRNAs by Cytoscape software. According to the expression level of lncRNAs, mRNAs and the clinical parameters, we also explored their relationship and evaluate their predictive values for embryos quality and PCOS. We identified 1,049 differential expressed lncRNAs and 3,246 mRNAs (fold-change ≥2, p-value < 0.05). Seven lncRNAs (NONHSAT101926.2, NONHSAT136825.2, NONHSAT227177.1, NONHSAT010538.2, NONHSAT191377.1, NONHSAT230904.1, ENST00000607307) and 3 mRNAs (EREG, ENTPD6, YAP1) were validated consistent with sequence profile. Seven lncRNAs were related to hormone level and follicle counts, 3 mRNAs had connections with lipid metabolism. The area under curve (AUC) of 7 lncRNAs were valuable in distinguishing patients with PCOS from Controls. The AUC of NONHSAT230904.1 and NONHSAT227177.1 were 0.6807 and 0.6410, respectively, for distinguishing whether the rate of high-quality embryos exceeds 50%. Our study showed that the GCs lncRNAs and mRNAs were involved in the occurrence and development of PCOS, which contribute to clarify the pathogenesis mechanism of PCOS.

Keywords